54 related articles for article (PubMed ID: 500231)
1. Heterotoxicity of human serum. IV. Role of the alternative complement pathway and natural antibody in the lethal toxicity of human serum for mice.
Rozenfarb E; Eidinger D
Int Arch Allergy Appl Immunol; 1979; 60(4):414-26. PubMed ID: 500231
[TBL] [Abstract][Full Text] [Related]
2. The activation of the alternative complement pathway by fetal calf serum and mouse thymocytes.
Eisenberg RA; Theofilopoulos AN; Dixon FJ
J Immunol; 1979 May; 122(5):2045-51. PubMed ID: 87451
[TBL] [Abstract][Full Text] [Related]
3. Activation of the alternative pathway of human complement by haemoglobin.
Wilson WA; Thomas EJ
Clin Exp Immunol; 1979 Apr; 36(1):140-4. PubMed ID: 111881
[TBL] [Abstract][Full Text] [Related]
4. Activation of the alternative complement pathway by normal and transformed cells in homologous and heterologous sera.
McConnell I; Gorman NT; Raniwalla J; Powell P
Eur J Immunol; 1981 Feb; 11(2):126-32. PubMed ID: 6260511
[TBL] [Abstract][Full Text] [Related]
5. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
Mosser DM; Edelson PJ
J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
[TBL] [Abstract][Full Text] [Related]
6. Lysis of horse red blood cells mediated by antibody-independent activation of the alternative pathway of chicken complement.
Ohta H; Yoshikawa Y; Kai C; Yamanouchi K; Okada H
Immunology; 1984 Jul; 52(3):437-44. PubMed ID: 6430791
[TBL] [Abstract][Full Text] [Related]
7. Alternate complement pathway activation by recluse spider venom.
Kurpiewski G; Campbell BJ; Forrester LJ; Barrett JT
Int J Tissue React; 1981 Mar; 3(1):39-45. PubMed ID: 7287056
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement.
Okada N; Harada R; Fujita T; Okada H
J Immunol; 1989 Oct; 143(7):2262-6. PubMed ID: 2476502
[TBL] [Abstract][Full Text] [Related]
9. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
Ekdahl KN; Nilsson B
J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
[TBL] [Abstract][Full Text] [Related]
10. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
Schenkein HA; Ruddy S
J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918
[TBL] [Abstract][Full Text] [Related]
11. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
Moore FD; Austen KF; Fearon DT
J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
[TBL] [Abstract][Full Text] [Related]
12. Effects of decomplementation on mercuric chloride-induced glomerulonephritis in Brown-Norway rats.
Capron M; Bascou C; Vial MC; Grossetete J; Hinglais N; Girard JF; Druet P
Clin Exp Immunol; 1982 Sep; 49(3):611-7. PubMed ID: 6216993
[TBL] [Abstract][Full Text] [Related]
13. [Concentration-functional interrelationships in the human alternative complement activation pathway].
Galebskaia LV; Shcherbak IG; Bel'tiukov PP; Riumina EV; Solovtsova IL
Biokhimiia; 1993 Nov; 58(11):1796-800. PubMed ID: 8268316
[TBL] [Abstract][Full Text] [Related]
14. Activation of the alternative pathway of complement by human peripheral nerve myelin.
Koski CL; Vanguri P; Shin ML
J Immunol; 1985 Mar; 134(3):1810-4. PubMed ID: 2578522
[TBL] [Abstract][Full Text] [Related]
15. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
Moore FD; Fearon DT; Austen KF
J Immunol; 1981 May; 126(5):1805-9. PubMed ID: 6908606
[No Abstract] [Full Text] [Related]
16. Heterotoxicity of human serum. V. Development of hematological abnormalities in mice suggestive of disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Rozenfarb E; Eidinger D
Int Arch Allergy Appl Immunol; 1979; 60(4):427-40. PubMed ID: 574127
[No Abstract] [Full Text] [Related]
17. Susceptibility of Giardia lamblia trophozoites to the lethal effect of human serum.
Hill DR; Burge JJ; Pearson RD
J Immunol; 1984 Apr; 132(4):2046-52. PubMed ID: 6699407
[TBL] [Abstract][Full Text] [Related]
18. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
19. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
Schreiber AD; Frank MM
J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
[TBL] [Abstract][Full Text] [Related]
20. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
